Metabolism Characteristics in the Children With Narcolepsy (Narcolepsy)

April 19, 2019 updated by: Hospices Civils de Lyon

Is There a Change in the Total Metabolism Over 24 Hours for Narcoleptic Children That Could Explain Their Tendency to Obesity?

A significant weight gain and obesity are observed for most patients with narcolepsy, mainly at the beginning of the disease and narcolepsy in young children. There is no specific study on the population and the consequences of overweight in the lives of these long-term patients. Narcoleptic patients gain weight significantly at the onset of their illness. It is also known that weight gain is not related to the treatment of narcolepsy. The etiology of obesity in narcoleptic patients is not established. Several assumptions were made (physical activity, leptin diet, metabolism). The reason and the pathophysiology of overweight and obesity in this population therefore remain unclear.

In this study, potential change in the total metabolism (24h) for narcoleptic children that could explain their tendency to obesity will be assessed ?

Study Overview

Status

Unknown

Conditions

Study Type

Interventional

Enrollment (Anticipated)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

      • Bron, France, 69677
        • Recruiting
        • Service d'Exploration et pathologie du sommeil, Hôpital Femme Mère Enfant
        • Contact:
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

6 years to 18 years (Child, Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

NARCOLEPTIC PATIENTS

  • Girl or boy age> 6 years <18 years;
  • Narcoleptic: defined by the ICSD diagnostic criteria 2 (International Classification of Sleep Disorders)
  • Beginning of the troubles there more than 6 months
  • Parental consent and agreement of the child.

HYPERSOMNIC PATIENTS

  • Girl or boy age> 6 years <18 years;
  • Hypersomnic : defined by the ICSD diagnostic criteria 2 (International Classification of Sleep Disorders)
  • Beginning of the troubles there more than 6 months
  • Parental consent and agreement of the child.

Exclusion Criteria:

NARCOLEPTIC PATIENTS

  • Secondary Narcolepsy;
  • Narcolepsy already treated with psychostimulant or anticataplectic;
  • Restless legs;
  • Sleep apnea syndrome;
  • Obesity known outside narcolepsy cause;
  • Absence of parental consent.

HYPERSOMNIC PATIENTS

  • symptomatic or secondary hypersomnia;
  • Hypersomnia already treated psychostimulant or anticataplectic; Restless legs;
  • Sleep apnea syndrome;
  • Pathology neurological, psychiatric, endocrine or concurrent;
  • Lack of parental consent

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: Narcoleptic patients
Other: hypersomnic patients

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Determination of the metabolism at home
Time Frame: 15 days
Total energy expenditure in kilocalories per minute, including basal metabolic rate (MET) metabolism related to the activity (EEA), and physical activity (PA) measured by accelerometer (Actical) evaluated at home (15 days including scholar and non-scholar days).
15 days

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Determination of the metabolism at hospital
Time Frame: 18 days
Total energy expenditure in kilocalories per minute, including basal metabolic rate (MET) metabolism related to the activity (EEA), and physical activity (PA) measured by accelerometer (Actical) evaluated at hospital over 24 hours.
18 days
Basal energy expenditure
Time Frame: 18 days
The basal metabolism (MET) measured by accelerometer (Actical, BodyMedia SW Actiheart) will be compared to the values of energy expenditure (kcal) measured by indirect calorimetry fasting.
18 days
Energy expenditure and diet-induced thermogenesis
Time Frame: 18 days
Energy expenditure (kcal) measured by indirect calorimetry after lunch (with counting calories ingested).
18 days
Sympathetic activity
Time Frame: 18 days
Estimated from IBI (Interbeat Interval) measured by Actiheart.
18 days
Food intake
Time Frame: 18 days
Caloric intake evaluation (kcal per day) during hospitalization (food intake recording) and at home during three days ( two days during the week and one day during the week-end) evaluated by questionnary.
18 days
Fasting peptide YY
Time Frame: 18 days
18 days
Body weight
Time Frame: 18 days
bodyweight (kg)
18 days
Body height
Time Frame: 18 days
Body height (cm)
18 days
Waist and hips circumference
Time Frame: 18 days
Waist and hips circumference (cm)
18 days
Measurement of neck
Time Frame: 18 days
Measurement of neck (cm)
18 days
Anthropometric measurements
Time Frame: 18 days
Measurement of BMI Z-score
18 days
Appetite
Time Frame: 18 days
appetite evaluation by visual analog scale before each meal
18 days
Hunger
Time Frame: 18 days
hunger evaluation by visual analog scale before each meal
18 days
Fasting IL6-8 levels
Time Frame: 18 days
18 days
Fasting adiponectin
Time Frame: 18 days
18 days
Fasting resistin
Time Frame: 18 days
18 days
Fasting MCP1
Time Frame: 18 days
18 days
Fasting PostPrandial
Time Frame: 18 days
18 days
Fasting GLP1 (glucagon-like peptide-1)
Time Frame: 18 days
18 days
Fasting Hba1C
Time Frame: 18 days
18 days
Body mass index z score
Time Frame: 18 days
18 days
sleep duration
Time Frame: 18 days
18 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 20, 2013

Primary Completion (Anticipated)

November 1, 2019

Study Completion (Anticipated)

November 1, 2019

Study Registration Dates

First Submitted

May 3, 2016

First Submitted That Met QC Criteria

June 14, 2016

First Posted (Estimate)

June 15, 2016

Study Record Updates

Last Update Posted (Actual)

April 22, 2019

Last Update Submitted That Met QC Criteria

April 19, 2019

Last Verified

April 1, 2019

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Narcolepsy

Clinical Trials on Sleep and metabolism assessment

3
Subscribe